Skip to main content

. 1971 Jun;173(6):864–871. doi: 10.1097/00000658-197106010-00003

Topical 5-FU--a new approach to skin cancer.

PMCID: PMC1397495 PMID: 5578800

864

Images in this article

Fig. 1. Fig. 2. Fig. 3. Fig. 4. Fig. 5. Fig. 6.
on p.865

Fig. 7. Fig. 8. Fig. 9. Fig. 10. Fig 11. Fig 12.
on p.867

Fig. 13. Fig. 14. Fig. 15. Fig. 16. Fig. 17. Fig. 18.
on p.869

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Allison J. R., Jr The topical use of Fluorouracil in the treatment of cancers and precancers. J S C Med Assoc. 1967 Jul;63(7):239–241. [PubMed] [Google Scholar]
DILLAHA C. J., JANSEN G. T., HONEYCUTT W. M., BRADFORD A. C. SELECTIVE CYTOTOXIC EFFECT OF TOPICAL 5-FLUOROURACIL. Arch Dermatol. 1963 Sep;88:247–256. doi: 10.1001/archderm.1963.01590210005001. [DOI] [PubMed] [Google Scholar]
GOLDMAN L. The response of skin cancer to topical therapy with 5-fluorouracil. Cancer Chemother Rep. 1963 Apr;28:49–52. [PubMed] [Google Scholar]
Klein E., Stoll H. L., Jr, Milgrom H., Traenkle H. L., Case R. W., Laor Y., Helm F., Nadel R. S. Tumors of the skin. V. Local administration of anti-tumor agents to multiple superficial basal cell carcinomas. J Invest Dermatol. 1965 Dec;45(6):489–495. [PubMed] [Google Scholar]
Sams W. M. Untoward response with topical fluorouracil. Arch Dermatol. 1968 Jan;97(1):14–22. [PubMed] [Google Scholar]
Sturm H. M., Scott H. Treatment of actinic keratoses with topical 5-fluorouracil. J Med Assoc Ga. 1968 May;57(5):205–209. [PubMed] [Google Scholar]
Williams A. C., Klein E. Experiences with local chemotherapy and immunotherapy in premalignant and malignant skin lesions. Cancer. 1970 Feb;25(2):450–462. doi: 10.1002/1097-0142(197002)25:2<450::aid-cncr2820250224>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES